Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report

被引:2
|
作者
Liu, Jing-Hua [1 ,2 ]
Gao, Qian [1 ]
Ma, Wen-Yi [1 ]
Cheng, Zi-Lin [1 ]
Luo, Na-Na [1 ]
Hao, Ping-Sheng [1 ,3 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Dept Dermatol, Chengdu, Sichuan, Peoples R China
[2] Dalian Dermatosis Hosp, Dalian, Liaoning, Peoples R China
[3] Hosp Chengdu Univ Tradit Chinese Med, 39 Shi er qiao Rd, Chengdu, Sichuan Provinc, Peoples R China
关键词
autoimmune bullous diseases; dupilumab; biologics; comorbidity; Chinese herbal compounds; USTEKINUMAB; THERAPY; PATIENT;
D O I
10.2147/CCID.S415019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is an immune-mediated chronic inflammatory disease that can be combined with complications such as diabetes, cardiovascular disease, obesity, and kidney disease. The comorbidity of psoriasis with autoimmune bullous diseases (AIBD) has been reported previously in several cases, the most frequent of which is bullous pemphigoid (BP). The underlying mechanisms of psoriasis with BP are not clear and there are no uniform treatment criteria. Based on previous case reports, the coexistence of psoriasis and BP may be related to inflammatory activity, medications, phototherapy, and infection. We report a case of a psoriasis patient who developed BP after taking Chinese herbal compounds and was successfully treated with dupilumab, which is the first reported case of applying dupilumab to treat psoriasis with BP comorbidities.
引用
下载
收藏
页码:1583 / 1587
页数:5
相关论文
共 50 条
  • [1] Case report: Dupilumab for the treatment of bullous pemphigoid
    Wang, Mengxin
    Wang, Juan
    Shi, Bingjun
    DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [2] Successful dupilumab treatment in bullous pemphigoid complicated with subacute hematogenous disseminated tuberculosis: A case report
    Dong, Qian
    Zheng, Rui
    He, Zhe
    Xi, Yue
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (07)
  • [3] Successful treatment of eczema-like bullous pemphigoid and typical bullous pemphigoid with dupilumab: two case reports
    Xu, Yanqin
    Song, Weicheng
    Cai, Yan
    Huang, Rong
    Wei, Junxiao
    Liu, Hui
    Peng, Xiaoming
    Zeng, Kang
    Li, Changxing
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (03) : E144 - E146
  • [4] Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report
    Yun, Jenny S. W.
    Scardamaglia, Laura
    Tan, Chin-Guan
    McCormack, Christopher J.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) : E155 - E158
  • [5] Successful secukinumab treatment of active bullous pemphigoid and chronic severe psoriasis: a case report
    Yun, Jenny S. W.
    Scardamaglia, Laura
    Tan, Chin-Guan
    McCormack, Chris
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 16 - 17
  • [7] Successful treatment of bullous pemphigoid with baricitinib: A case report
    Ma, Jun
    Chiang, Chien-Ping
    Wang, Wei-Ming
    Hung, Chih-Tsung
    Chen, Yi-Hsien
    DERMATOLOGICA SINICA, 2023, 41 (03) : 176 - 177
  • [8] Dupilumab for the treatment of pembrolizumab-induced bullous pemphigoid: A case report
    Pop, Samantha R.
    Strock, Daniel
    Smith, Robert J.
    DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [9] A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis
    Loget, J.
    Plee, J.
    Antonicelli, F.
    Bernard, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (05) : e228 - e230
  • [10] Successful Treatment of Mucous Membrane Pemphigoid with Dupilumab: A Case Report
    Wang, Zhiyi
    Liu, Xiaojing
    Ni, Jing
    Qi, Yushuo
    Song, Zhiqi
    Piao, Yongjun
    ACTA DERMATO-VENEREOLOGICA, 2024, 104